Data presented on the EURneffy/neffy adrenaline (epinephrine) nasal spray at the European Academy of Allergy & Clinical ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

In fact, many people experience nosebleeds as the temperature rises, and there’s more to it than meets the eye. Nosebleeds ...

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how so-called “magic mushrooms” could help with a range of mental health ...

Vaccine experts have developed an antibody that, when applied to the nose, intercepts allergens before they can trigger a ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

A rapidly growing weed may cause hayfever sufferers to battle symptoms longer this year as it could pose a threat to ...

Sinus pain and headaches can be symptoms of the common cold, allergies, or sinusitis. Learn how to relieve sinus pressure and pain instantly, with methods including hot compresses and spicy foods.

World Allergy Day 2025 highlights anaphylaxis, a severe allergic reaction requiring immediate action. Affecting millions ...